Literature DB >> 2412632

Bronchoalveolar mast cells in extrinsic asthma: a mechanism for the initiation of antigen specific bronchoconstriction.

K C Flint, K B Leung, B N Hudspith, J Brostoff, F L Pearce, N M Johnson.   

Abstract

Bronchoalveolar lavage performed in 10 patients with extrinsic asthma and 14 controls yielded similar recoveries of fluid and cells. Mast cells and eosinophils, however, formed a greater proportion of the cells recovered from the asthmatic subjects (p less than 0.001 for mast cells; p less than 0.01 for eosinophils), the histamine content of the lavage cells being correspondingly increased (p less than 0.01). Both the percentage of mast cells and the histamine content of lavage cells were significantly inversely correlated with the forced expiratory volume in one second (FEV1; expressed as percentage of predicted) and with the ratio of FEV1 to forced vital capacity before lavage. There was also a significant inverse correlation between the concentration of histamine required to produce a 20% fall in FEV1 and the percentage of mast cells recovered (p less than 0.05). When incubated with antihuman IgE bronchoalveolar mast cells from asthmatic subjects released a significantly increased proportion of total cellular histamine than cells from control subjects at all effective doses of anti-IgE. By contrast, dose response curves for IgE dependent histamine release from peripheral blood leucocytes were similar in asthmatics and controls. Specific antigen led to release of histamine from bronchoalveolar cells and peripheral blood leucocytes of asthmatic subjects but not controls. Lying superficially within the airways, bronchoalveolar mast cells would be readily exposed to inhaled antigen and would release mediators directly on to the airway surface. Their immunological response suggests that they are likely to be important in the pathogenesis of airflow obstruction in asthma.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2412632      PMCID: PMC1417238          DOI: 10.1136/bmj.291.6500.923

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  13 in total

1.  Mast cells in rat gastrointestinal mucosa. I. Effects of fixation.

Authors:  L Enerbäck
Journal:  Acta Pathol Microbiol Scand       Date:  1966

2.  Isolation and characteristics of gut mucosal lymphocytes.

Authors:  O Rudzik; J Bienenstock
Journal:  Lab Invest       Date:  1974-03       Impact factor: 5.662

3.  Bronchoalveolar lavage. Its safety in subjects with mild asthma.

Authors:  J A Rankin; P E Snyder; E N Schachter; R A Matthay
Journal:  Chest       Date:  1984-06       Impact factor: 9.410

4.  Immunoglobulin secreting cells in normal human bronchial lavage fluids.

Authors:  E C Lawrence; R M Blaese; R R Martin; P M Stevens
Journal:  J Clin Invest       Date:  1978-10       Impact factor: 14.808

5.  Sodium cromoglycate in histamine and methacholine reactivity in asthma.

Authors:  K R Patel
Journal:  Clin Allergy       Date:  1984-03

6.  Functional assessment of alveolar macrophages: comparison of cells from asthmatics and normal subjects.

Authors:  P Godard; J Chaintreuil; M Damon; M Coupe; O Flandre; A Crastes de Paulet; F B Michel
Journal:  J Allergy Clin Immunol       Date:  1982-08       Impact factor: 10.793

7.  Passive anaphylaxis in human lung fragments as a model for testing anti-allergic drugs: its variability and constraints.

Authors:  K D Young; M K Church
Journal:  Int Arch Allergy Appl Immunol       Date:  1983

8.  Involvement of immunoglobulin E in the secretory processes of alveolar macrophages from asthmatic patients.

Authors:  M Joseph; A B Tonnel; G Torpier; A Capron; B Arnoux; J Benveniste
Journal:  J Clin Invest       Date:  1983-02       Impact factor: 14.808

9.  Comparative studies of human basophils and mast cells.

Authors:  D W MacGlashan; R P Schleimer; S P Peters; E S Schulman; G K Adams; A K Sobotka; H H Newball; L M Lichtenstein
Journal:  Fed Proc       Date:  1983-05-15

10.  Mast cells in bronchoalveolar lumen of patients with bronchial asthma.

Authors:  M Tomioka; S Ida; Y Shindoh; T Ishihara; T Takishima
Journal:  Am Rev Respir Dis       Date:  1984-06
View more
  30 in total

Review 1.  Cytokines in asthma.

Authors:  K F Chung; P J Barnes
Journal:  Thorax       Date:  1999-09       Impact factor: 9.139

Review 2.  Pathophysiological mechanisms of asthma. Application of cell and molecular biology techniques.

Authors:  K F Chung; I M Adcock
Journal:  Mol Biotechnol       Date:  2001-07       Impact factor: 2.695

Review 3.  The pharmacology of airway hyperresponsiveness and inflammation.

Authors:  R Pauwels
Journal:  Lung       Date:  1990       Impact factor: 2.584

Review 4.  Leukocyte activation following IgE dependent mechanisms in bronchial asthma.

Authors:  S R Durham
Journal:  Clin Rev Allergy       Date:  1989

5.  Seasonal increase of spontaneous histamine release in washed leucocytes from rhinitis patients sensitive to grass pollen.

Authors:  A Weyer; M T Guinnepain; J P Sutra; A Borgnon; N Herpin-Richard; M R Ickovic; J Meaume; M Raffard; F Tekaia
Journal:  Clin Exp Immunol       Date:  1990-03       Impact factor: 4.330

Review 6.  Chemokines and their receptors as potential targets for the treatment of asthma.

Authors:  C Palmqvist; A J Wardlaw; P Bradding
Journal:  Br J Pharmacol       Date:  2007-04-30       Impact factor: 8.739

Review 7.  Bronchoalveolar lavage as a research tool.

Authors:  E H Walters; P V Gardiner
Journal:  Thorax       Date:  1991-09       Impact factor: 9.139

8.  Effects of sodium cromoglycate and nedocromil sodium on histamine secretion from human lung mast cells.

Authors:  K B Leung; K C Flint; J Brostoff; B N Hudspith; N M Johnson; H Y Lau; W L Liu; F L Pearce
Journal:  Thorax       Date:  1988-10       Impact factor: 9.139

9.  Asthma: eosinophil disease, mast cell disease, or both?

Authors:  Peter Bradding
Journal:  Allergy Asthma Clin Immunol       Date:  2008-06-15       Impact factor: 3.406

10.  Virus-induced airway inflammation and hyperresponsiveness in the guinea-pig is inhibited by levodropropizine.

Authors:  G Folkerts; H J van der Linde; C Omini; F P Nijkamp
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-08       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.